Close Menu

NEW YORK (GenomeWeb) – In a lawsuit filed with the Superior Court of the State of California late Wednesday, Agilent Technologies has claimed that Twist Bioscience, its Founder and CEO Emily LeProust, and 20 other unnamed defendants, have stolen a certain genomics technology from Agilent.

"Emily LeProust is a scientist who, in a premeditated plan, stole industry-leading genomics technology from her longtime employer, Agilent Technologies, to start her own competitive company, Twist Bioscience," the complaint reads.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new blood test might be able to detect the presence of some 50 cancers, according to New Scientist.

Undark looks into how coronavirus-related shutdowns are affecting field researchers.

In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.